Weighted Average Number of Shares Outstanding, Diluted of Medpace Holdings, Inc. from 30 Sep 2015 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Medpace Holdings, Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 30 Sep 2015 to 31 Dec 2025.
  • Medpace Holdings, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 31 Dec 2025 was 29,527,000, a 7.8% decline year-over-year.
  • Medpace Holdings, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2025 was 29,527,000, a 7.8% decline from 2024.
  • Medpace Holdings, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 32,014,000, a 0.54% increase from 2023.
  • Medpace Holdings, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 31,841,000, a 5.4% decline from 2022.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

Medpace Holdings, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 29,527,000 -2,487,000 -7.8% 01 Oct 2025 31 Dec 2025 10-K 10 Feb 2026 2025 FY
Q3 2025 28,817,000 -3,271,000 -10% 01 Jul 2025 30 Sep 2025 10-Q 23 Oct 2025 2025 Q3
Q2 2025 29,143,000 -2,943,000 -9.2% 01 Apr 2025 30 Jun 2025 10-Q 22 Jul 2025 2025 Q2
Q1 2025 31,196,000 -805,000 -2.5% 01 Jan 2025 31 Mar 2025 10-Q 22 Apr 2025 2025 Q1
Q4 2024 32,014,000 +173,000 +0.54% 01 Oct 2024 31 Dec 2024 10-K 10 Feb 2026 2025 FY
Q3 2024 32,088,000 +326,000 +1% 01 Jul 2024 30 Sep 2024 10-Q 23 Oct 2025 2025 Q3
Q2 2024 32,086,000 +511,000 +1.6% 01 Apr 2024 30 Jun 2024 10-Q 22 Jul 2025 2025 Q2
Q1 2024 32,001,000 -154,000 -0.48% 01 Jan 2024 31 Mar 2024 10-Q 22 Apr 2025 2025 Q1
Q4 2023 31,841,000 -1,830,000 -5.4% 01 Oct 2023 31 Dec 2023 10-K 10 Feb 2026 2025 FY
Q3 2023 31,762,000 -491,000 -1.5% 01 Jul 2023 30 Sep 2023 10-Q 22 Oct 2024 2024 Q3
Q2 2023 31,575,000 -2,120,000 -6.3% 01 Apr 2023 30 Jun 2023 10-Q 23 Jul 2024 2024 Q2
Q1 2023 32,155,000 -4,209,000 -12% 01 Jan 2023 31 Mar 2023 10-Q 23 Apr 2024 2024 Q1
Q4 2022 33,671,000 -4,026,000 -11% 01 Oct 2022 31 Dec 2022 10-K 11 Feb 2025 2024 FY
Q3 2022 32,253,000 -5,266,000 -14% 01 Jul 2022 30 Sep 2022 10-Q 24 Oct 2023 2023 Q3
Q2 2022 33,695,000 -4,019,000 -11% 01 Apr 2022 30 Jun 2022 10-Q 25 Jul 2023 2023 Q2
Q1 2022 36,364,000 -1,385,000 -3.7% 01 Jan 2022 31 Mar 2022 10-Q 25 Apr 2023 2023 Q1
Q4 2021 37,697,000 -11,000 -0.03% 01 Oct 2021 31 Dec 2021 10-K 13 Feb 2024 2023 FY
Q3 2021 37,519,000 -244,000 -0.65% 01 Jul 2021 30 Sep 2021 10-Q 25 Oct 2022 2022 Q3
Q2 2021 37,714,000 +386,000 +1% 01 Apr 2021 30 Jun 2021 10-Q 26 Jul 2022 2022 Q2
Q1 2021 37,749,000 -281,000 -0.74% 01 Jan 2021 31 Mar 2021 10-Q 26 Apr 2022 2022 Q1
Q4 2020 37,708,000 +132,000 +0.35% 01 Oct 2020 31 Dec 2020 10-K 14 Feb 2023 2022 FY
Q3 2020 37,763,000 -72,000 -0.19% 01 Jul 2020 30 Sep 2020 10-Q 26 Oct 2021 2021 Q3
Q2 2020 37,328,000 -61,000 -0.16% 01 Apr 2020 30 Jun 2020 10-Q 27 Jul 2021 2021 Q2
Q1 2020 38,030,000 +745,000 +2% 01 Jan 2020 31 Mar 2020 10-Q 27 Apr 2021 2021 Q1
Q4 2019 37,576,000 +664,000 +1.8% 01 Oct 2019 31 Dec 2019 10-K 15 Feb 2022 2021 FY
Q3 2019 37,835,000 +710,000 +1.9% 01 Jul 2019 30 Sep 2019 10-Q 27 Oct 2020 2020 Q3
Q2 2019 37,389,000 +725,000 +2% 01 Apr 2019 30 Jun 2019 10-Q 28 Jul 2020 2020 Q2
Q1 2019 37,285,000 +836,000 +2.3% 01 Jan 2019 31 Mar 2019 10-Q 29 Apr 2020 2020 Q1
Q4 2018 36,912,000 -2,927,000 -7.3% 01 Oct 2018 31 Dec 2018 10-K 16 Feb 2021 2020 FY
Q3 2018 37,125,000 -2,204,000 -5.6% 01 Jul 2018 30 Sep 2018 10-Q 29 Oct 2019 2019 Q3
Q2 2018 36,664,000 -4,161,000 -10% 01 Apr 2018 30 Jun 2018 10-Q 30 Jul 2019 2019 Q2
Q1 2018 36,449,000 -5,059,000 -12% 01 Jan 2018 31 Mar 2018 10-Q 30 Apr 2019 2019 Q1
Q4 2017 39,839,000 +3,510,000 +9.7% 01 Oct 2017 31 Dec 2017 10-K 25 Feb 2020 2019 FY
Q3 2017 39,329,000 +1,706,000 +4.5% 01 Jul 2017 30 Sep 2017 10-Q 30 Oct 2018 2018 Q3
Q2 2017 40,825,000 +7,997,000 +24% 01 Apr 2017 30 Jun 2017 10-Q 31 Jul 2018 2018 Q2
Q1 2017 41,508,000 +8,883,000 +27% 01 Jan 2017 31 Mar 2017 10-Q 01 May 2018 2018 Q1
Q4 2016 36,329,000 01 Oct 2016 31 Dec 2016 10-K 26 Feb 2019 2018 FY
Q3 2016 37,623,000 +6,193,000 +20% 01 Jul 2016 30 Sep 2016 10-Q 31 Oct 2017 2017 Q3
Q2 2016 32,828,000 01 Apr 2016 30 Jun 2016 10-Q 01 Aug 2017 2017 Q2
Q1 2016 32,625,000 01 Jan 2016 31 Mar 2016 10-Q 02 May 2017 2017 Q1
Q3 2015 31,430,000 01 Jul 2015 30 Sep 2015 10-Q 03 Nov 2016 2016 Q3

Medpace Holdings, Inc. Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 29,527,000 -2,487,000 -7.8% 01 Jan 2025 31 Dec 2025 10-K 10 Feb 2026 2025 FY
2024 32,014,000 +173,000 +0.54% 01 Jan 2024 31 Dec 2024 10-K 10 Feb 2026 2025 FY
2023 31,841,000 -1,830,000 -5.4% 01 Jan 2023 31 Dec 2023 10-K 10 Feb 2026 2025 FY
2022 33,671,000 -4,026,000 -11% 01 Jan 2022 31 Dec 2022 10-K 11 Feb 2025 2024 FY
2021 37,697,000 -11,000 -0.03% 01 Jan 2021 31 Dec 2021 10-K 13 Feb 2024 2023 FY
2020 37,708,000 +132,000 +0.35% 01 Jan 2020 31 Dec 2020 10-K 14 Feb 2023 2022 FY
2019 37,576,000 +664,000 +1.8% 01 Jan 2019 31 Dec 2019 10-K 15 Feb 2022 2021 FY
2018 36,912,000 -2,927,000 -7.3% 01 Jan 2018 31 Dec 2018 10-K 16 Feb 2021 2020 FY
2017 39,839,000 +3,510,000 +9.7% 01 Jan 2017 31 Dec 2017 10-K 25 Feb 2020 2019 FY
2016 36,329,000 +4,983,000 +16% 01 Jan 2016 31 Dec 2016 10-K 26 Feb 2019 2018 FY
2015 31,346,000 01 Jan 2015 31 Dec 2015 10-K 27 Feb 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.